Loading...
  • normothermic
  • Although the benefits to the myocardium are generally accepted, there is conflicting data on cerebral damage after normothermic bypass. (asahq.org)
  • One minor weakness is the lack of a discussion of "normothermic" bypass in the chapter covering temperature management (this subject is addressed somewhat in the chapter on the neurologic effects of CPB). (asahq.org)
  • onset
  • With the onset of cardiopulmonary bypass and hence, removal of the lung and pulmonary converting enzyme from the circulation, there was a further rise in the already elevated concentrations of bradykinin. (ahajournals.org)
  • cerebral
  • It is likely, therefore, that the brain suffers some insults during bypass, and the use of hypothermia to provide cerebral protection has been advocated. (asahq.org)
  • renal
  • hepatorenal bypass insertion of a vascular prosthesis between the common hepatic artery and the renal artery, serving as a passage around an occluded segment of renal artery. (thefreedictionary.com)
  • endothelin
  • Although the administration of ATP reduced the increase in serum catecholamine concentration, there were no significant changes in other vasoactive mediators (eicosanoid, angiotensin II, endothelin) between the two groups during cardiopulmonary bypass. (biomedsearch.com)
  • treatment
  • Therefore, a new hypothesis risen: 'the change of the function and the number of monocyte subsets induced by emergency hematopoiesis play an important role for SIRS occurrence after cardiopulmonary bypass, correcting emergency hematopoiesis is a new breakthrough in the prevention and treatment of SIRS. (clinicaltrials.gov)
  • techniques
  • Although we are well aware of the techniques for establishing, maintaining, and discontinuing cardiopulmonary bypass, we surgeons are sometimes unaware of all the work that goes on across the "blood brain barrier. (ctsnet.org)
  • equipment
  • It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiopulmonary Bypass Equipment pipeline products.This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. (medindia.net)